Chordia Therapeutics Balance Sheet

Financials in millions JPY. Fiscal year is September - August.

Millions JPY. Fiscal year is Sep - Aug.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Nov '25 Nov 30, 2025	Aug '25 Aug 31, 2025	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023
Cash & Equivalents	2,336	2,549	4,330	4,799
Cash & Short-Term Investments	2,336	2,549	4,330	4,799
Cash Growth	-32.02%	-41.13%	-9.78%	-
Prepaid Expenses	26.24	24.9	38.16	52.06
Other Current Assets	104.64	95.18	237.64	40.52
Total Current Assets	2,467	2,669	4,605	4,892
Property, Plant & Equipment	-	-	2.75	4.43
Other Intangible Assets	-	-	0.62	2.5
Other Long-Term Assets	12.26	12.32	23.59	10.59
Total Assets	2,479	2,681	4,632	4,909
Accounts Payable	84.52	120.01	382.43	248.43
Accrued Expenses	12.9	29.33	2.3	25.6
Current Income Taxes Payable	3.86	90.5	54.29	2.42
Other Current Liabilities	82.38	4.5	32.06	131.79
Total Current Liabilities	183.65	244.34	471.07	408.24
Other Long-Term Liabilities	0	0	0	-
Total Liabilities	183.65	244.34	471.07	408.24
Common Stock	948.43	876.27	845.27	90
Additional Paid-In Capital	1,630	9,066	9,035	8,280
Retained Earnings	-295.32	-7,508	-5,722	-3,895
Comprehensive Income & Other	12.04	2.52	2.94	25.93
Shareholders' Equity	2,296	2,437	4,161	4,501
Total Liabilities & Equity	2,479	2,681	4,632	4,909
Net Cash (Debt)	2,336	2,549	4,330	4,799
Net Cash Growth	-32.02%	-41.13%	-9.78%	-
Net Cash Per Share	33.84	37.15	73.72	85.02
Filing Date Shares Outstanding	70.27	68.99	67.68	56.44
Total Common Shares Outstanding	70.27	68.99	67.68	56.44
Working Capital	2,283	2,425	4,134	4,483
Book Value Per Share	32.67	35.32	61.49	79.74
Tangible Book Value	2,296	2,437	4,161	4,498
Tangible Book Value Per Share	32.67	35.32	61.48	79.70
Machinery	10.48	10.48	11.21	10.68

Updated Nov 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.